The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study

The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study

Jiangtao Yu,1,2,* Ziwen Xu,3,* Anyang Li,2 Jindi Zhang,2 Yi Wang,4 Hongqin Zhao,2 Haiyan Zhu1,2 1Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200126, People’s Republic of China; 2Department of Gynecology, The First A...

Full description

Bibliographic Details
Main Authors: Yu J, Xu Z, Li A, Zhang J, Wang Y, Zhao H, Zhu H
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Drug Design, Development and Therapy
Subjects:
Epidermal growth factor receptor
Apatinib
cervical cancer
metastatic or recurrent
efficacy.
Online Access:https://www.dovepress.com/the-efficacy-and-safety-of-apatinib-treatment-for-patients-with-metast-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/the-efficacy-and-safety-of-apatinib-treatment-for-patients-with-metast-peer-reviewed-article-DDDT

Similar Items